1-18 of 18
Xiaoqi Qin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of aponermin +kt-decp in patients(pts) with Relapsed/Refractory multiple myeloma and extramedullary disease

Free
Menghan Liu, Xiaoqi Qin, Weiwei Tian, Yuechen Zhang, Yanru Zhang, Lefu Huang, Wenjing Li, Jingrong Wang, Yanping Ma, Liping Su, Yan Yan, Aijun Liao, Wenming Chen, Aijun Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2280.
https://doi.org/10.1182/blood-2025-2280
Published: 2025
Journal Articles

Efficacy and safety of aponermin-carfilzomib-dexamethasone-based regimens for relapsed/refractory multiple myeloma: A Phase 2 prospective multi-center study

Free
Huixing Zhou, Chunrui Li, Baijun Fang, Lingzhi Yan, Aijun Liu, Peiling Zhang, Yang Liu, Xiaoqi Qin, Huanxin Zhang, Wei Zhou, Hong-Hu Zhu, Leng Yun, Yin WU, Yi Wang, Wenming Chen, Guangzhong Yang
Journal: Blood
Blood (2025) 146 (Supplement 1): 2271.
https://doi.org/10.1182/blood-2025-2271
Published: 2025
Journal Articles

Daratumumab-based therapy for newly diagnosed multiple myeloma patients with renal impairment：a multicenter retrospective study from China

Free
Yingying Ye, Long Chang, Jun Luo, Hua Wang, Chong Wang, Wei WANG, Hui-Han Wang, Qingming Wang, Songfu Jiang, Juan Du, Junqing Xv, Haiping Yang, Xiaoqi Qin, Huang Hongming, Hua Xue, Junbai Fang, Weiwei Tian, He-Bing Zhou, Wen-Rong Huang, Ying Zhao, Jingnan Sun, Ying Sun, Wenming Chen, Hong-Hu Zhu, Jian Li, Wen Gao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7546.
https://doi.org/10.1182/blood-2025-7546
Published: 2025
Journal Articles

Efficacy and safety of aponermin combined with immunomodulators in relapsed/refractory multiple myeloma

Free
Xiujuan Huang, Yanping Ma, Zhenyu Li, Juan Li, Yuzhang Liu, Yaomei Wang, Chao Song, Xiaoqi Qin, Wenming Chen, Yi Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 7571.
https://doi.org/10.1182/blood-2025-7571
Published: 2025
Journal Articles

Renal response of selinexor,  bortezomib, pomalidomide, and dexamethasone in newly diagnosed multiple myeloma patients with renal impairment: A phase 2, prospective, multicenter study

Free
Huixing Zhou, Long Chang, Jie Ma, Songying Zhao, Jingnan Sun, Sun Liping, Xiaoqi Qin, Hongmei Jing, Jingrong Wang, He-Bing Zhou, Xiaolei Chen, Hai Zhou, Zhenling Li, Wenrong Huang, Yi Ma, Guohong Su, Jun Luo, Guoxiang Zhang, Biyun Chen, Weiwei Tian, Guang-Yu Ma, Jihao Zhou, Wenming Chen, Hong-Hu Zhu, Jian Li, Wen Gao
Journal: Blood
Blood (2025) 146 (Supplement 1): 5830.
https://doi.org/10.1182/blood-2025-5830
Published: 2025
Journal Articles

Dynamic evolution of minimal residual disease and normal plasma cells following autologous stem cell transplantation in multiple myeloma

Free
Qirui Bai, Wenqiang Yan, Xiaoqi Qin, Lugui Qiu, Gang An
Journal: Blood
Blood (2025) 146 (Supplement 1): 2241.
https://doi.org/10.1182/blood-2025-2241
Published: 2025
Journal Articles

Ixazomib, Pomalidomide and Dexamethasone (IxaPD) Pan-Oral Regimen in the Treatment of Refractory and Relapsed Multiple Myeloma

Free
Miao Chen, Hong Yu, Aijun Liu, Wei Wang, Xiaoqi Qin, Ziping Li, Yanping Ma, Wenming Chen, Rong Fu, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7038.
https://doi.org/10.1182/blood-2024-210284
Published: 2024
Journal Articles

Carfilzomib, Pomalidomide, Dexamethasone with and without Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multi-Center, Prospective Real World Study in China

Free
Fujing Zhang, Wei Wang, Hua Wang, Wei Wang, Aijun Liu, Weiwei Tian, Xiaoqi Qin, Zhongjun Xia, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6985.
https://doi.org/10.1182/blood-2024-209342
Published: 2024
Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Free
Chuanying Geng, Jing Lu, Xiaozhe Li, Qiang Li, Na Li, Weiwei Tian, Jie Zhao, Guangzhong Yang, Yanping Ma, Xiaoqi Qin, Jing Jia, Huixing Zhou, Lintao Bi, Chenchen Wang, Ying Sun, Xiantao Liu, Yuan Jian, Qingming Wang, Haixiang Wan, Jinqiao Zhang, Han Liu, Hui Geng, Xiaojing Ma, Yunxia Liang, Rui Hu, Da Gao, Donghai Han, Haisheng Liu, Guangyu Ma, Zhihua Zhang, Wei Wang, Shi Minxia, Bo Nie, Zhang Hong, Jie Li, Guitao Jie, Meiying Fan, Qinglin Song, Wenyong Li, Zhenfang Xi, Guorong Gao, Jie Liu, Zhihua Li, Hua Xue, Huimei Guo, Jie Li, Xiaohan Gao, Guo-Hong Su, Jie Shen, ARong Jin, Peng Lv, Wenming Chen, Juan Li, Juan Du, Wen Gao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6925.
https://doi.org/10.1182/blood-2024-205155
Published: 2024
Journal Articles

Clonal Heterogeneity and Evolutionary Phylogeny of Critical Cytogenetic Aberrations in Multiple Myeloma

Free
Yuting Yan, Xiaoqi Qin, Jiahui Liu, Huishou Fan, Lanting Liu, Zhen Yu, Shuhui Deng, Wei Liu, Dehui Zou, Lugui Qiu, Gang An
Journal: Blood
Blood (2021) 138 (Supplement 1): 1608.
https://doi.org/10.1182/blood-2021-152794
Published: 2021
Journal Articles

Clonal Phylogeny and Evolution of Critical Cytogenetic Aberrations in Multiple Myeloma at Single Cell Level

Free
Yuting Yan, Xiaoqi Qin, Lanting Liu, Shuhui Deng, MD, Jiahui Liu, Huishou Fan, Weiwei Sui, MD, Fu Mingwei, MD, Xue-Han Mao, MD, Zhen Yu, MD, Dehui Zou, MD, Lugui Qiu, MD, Gang An, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-143447
Published: 2020
Journal Articles

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Free
Meirong Zang, Lanting LIU, Fengyan Jin, Jiaojiao Guo, An Gang, MD, Xiaoqi Qin, Tao Zhu, Shuhui Deng, Zhang Shuaishuai, MD, Mu Hao, PhD, Xiaoyan Feng, Yan Xu, MD, Wen Zhou, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4350.
https://doi.org/10.1182/blood.V130.Suppl_1.4350.4350
Published: 2017
Journal Articles

Voriconazole Increase the Risk of PN in Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy

Free
Yan Xu, MDPhD, Shuhui Deng, MD, Gang An, MDPhD, Zengjun Li, Sr., Xiaoqi Qin, MD, Weiwei Sui, MD, Xiaoyan Feng, Dehui Zou, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5394.
https://doi.org/10.1182/blood.V126.23.5394.5394
Published: 2015
Journal Articles

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Free
Meirong Zang, Fengyan Jin, Lanting Liu, Gang An, MDPhD, Xiaoqi Qin, MD, Xiaoyan Feng, Yan Xu, MDPhD, Mu Hao, MD PhD, Wen Zhou, PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2480.
https://doi.org/10.1182/blood.V126.23.2480.2480
Published: 2015
Journal Articles

Clonal Evolution Paths Significantly Impact the Outcome of Myeloma

Free
Xiaoqi Qin, MD, Gang An, MDPhD, Lin-ping Hu, MD, Yu Qin, MD PhD, Yan Xu, MDPhD, Xiaoyan Feng, Meirong Zang, Shuhui Deng, MD PhD, Weiwei Sui, MD, Shuhua Yi, MD PhD, Zengjun Li, Sr., Lin-hua Yang, MD, Tao Cheng, MD, Jianxiang Wang, MD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1784.
https://doi.org/10.1182/blood.V126.23.1784.1784
Published: 2015
Journal Articles

Unmeasurable Serum M-Protein Multiple Myeloma Benefit Less from Bortezomib Than Measurable Myeloma

Free
Xiaoqi Qin, Gang An, MD PhD, Yan Xu, MD PhD, Yu Qin, PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 2062.
https://doi.org/10.1182/blood.V124.21.2062.2062
Published: 2014
Journal Articles

MiR-137 Contributes to Drug Susceptibility and Chromosomal Instability of Multiple Myeloma through Targeting AURKA

Free
Yu Qin, PhD, Fei Li, MD, Xiaoqi Qin, Gang An, MD PhD, Mu Hao, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Wen Zhou, PhD, Hong Chang, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 5715.
https://doi.org/10.1182/blood.V124.21.5715.5715
Published: 2014
Journal Articles

Clonal Heterogeneityand Evolutional Paths in Multiple Myeloma Revealed By QM-FISH in Single Cell of Sequential Analysis

Free
Xiaoqi Qin, Gang An, MD PhD, Yu Qin, PhD, Yan Xu, MD PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3395.
https://doi.org/10.1182/blood.V124.21.3395.3395
Published: 2014